Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 4/20 | 0.48 |
| ▸ | CTSL | P07711 | 2/20 | 0.48 |
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5898498 | 1.00 | CTSK (0.48) | CTSKCTSLCTSSCTSBATM | |
| SCHEMBL11982516 | 0.81 | CTSK (0.51) | CTSKCTSLCTSSCTSBATM | |
| SCHEMBL1643095 | 0.81 | CTSK (0.51) | CTSKCTSLCTSSCTSBATM | |
| SCHEMBL851513 | 0.80 | CTSK (0.45) | CTSKCTSLCTSSCTSBATM | |
| SCHEMBL8798293 | 0.78 | CTSK (0.54) | CTSKCTSLCTSSCTSBATM | |
| SCHEMBL9744407 | 0.78 | CTSK (0.52) | CTSKCTSLCTSSCTSBATM | |
| SCHEMBL522838 | 0.76 | ALDH1A1 (0.57) | KCNA5LMNAKMT2AALDH1A1 | |
| SCHEMBL6986082 | 0.76 | CTSK (0.59) | CTSKCTSLCTSSCTSBATM | |
| SCHEMBL241564 | 0.76 | CTSK (0.61) | CTSKCTSLCTSSCTSBATM | |
| SCHEMBL241565 | 0.76 | CTSK (0.61) | CTSKCTSLCTSSCTSBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7026515-B2 | Optically active amine derivatives and preparation process therefor | MITSUI CHEMICALS, INC. (JP) | 2006-04-11 | — | — | US | disclosed |
| US-20040030144-A1 | Optically active amine derivative and method of synthesis | MITSUI CHEMICALS, INC. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1340743-A1 | OPTICALLY ACTIVE AMINE DERIVATIVE AND METHOD OF SYNTHESIS | Mitsui Chemicals, Inc. (JP) | 2003-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040030144-A1 | Optically active amine derivative and method of synthesis | ALDH7A1, AADAT, KMO | CTSK 1631/4885CTSL 1396/4885CTSS 2530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.